Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan diabetes complications study

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2803-2809

  Moriya, Tatsumi ^a   Tanaka, Shiro ^b   Kawasaki, Ryo ^b   Ohashi, Yasuo ^d   Akanuma, Yasuo ^e   Yamada, Nobuhiro ^f   Sone, Hirohito ^g   Yamashita, Hidetoshi ^c   Katayama, Shigehiro ^h  

^a KITASATO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e INSTITUTE FOR ADULT DISEASES   (Japan)

^f UNIVERSITY OF TSUKUBA   (Japan)

^g NIIGATA UNIVERSITY   (Japan)

^h SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ALBUMIN TO CREATININE RATIO; ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; INCIDENCE; JAPANESE; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ALBUMINURIA; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KIDNEY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 84891774080     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2327     Document Type: Article

References (37)

1. Pedro RA, Ramon SA, Marc BB, Juan FB, Isabel MM. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North- East of Spain, a population-based study. Ophthalmic Epidemiol 2010;17: 251-265
2. Parving HH, Gall MA, Skøtt P, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992;41: 758-762
3. Klein R, Zinman B, Gardiner R, et al.; Renin-Angiotensin System Study. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin- Angiotensin System Study. Diabetes 2005; 54: 527-533
4. Chavers BM, Mauer SM, Ramsay RC, Steffes MW. Relationship between retinal and glomerular lesions in IDDM patients. Diabetes 1994;43: 441-446
5. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999;341: 1127-1133
6. Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000;49: 1399-1408
7. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987;31: 673-689
8. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulindependent patients. N Engl J Med 1984; 311: 89-93
9. Katayama S, Moriya T, Tanaka S, et al.; Japan Diabetes Complications Study Group. Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS). Diabetologia 2011;54: 1025-1031
10. Perkins BA, Ficociello LH, Ostrander BE, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 2007; 18: 1353-1361
11. Wirta O, Pasternack A, Mustonen J, Laippala P, Lähde Y. Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus. Clin Nephrol 1999;51: 329-334
12. Kim KS, Koh JM, Song KH, et al. Incidence of overt proteinuria and coronary artery disease in patients with type 2 diabetes mellitus: the role of microalbuminuria and retinopathy. Diabetes Res Clin Pract 2004;65: 159-165
13. Karlberg C, Falk C, Green A, Sjølie AK, Grauslund J. Proliferative retinopathy predicts nephropathy: a 25-year followup study of type 1 diabetic patients. Acta Diabetol 2012;49: 263-268
14. Takazakura E, Nakamoto Y, Hayakawa H, Kawai K, Muramoto S. Onset and progression of diabetic glomerulosclerosis; a prospective study based on serial renal biopsies. Diabetes 1975;24: 1-9
15. Sone H, Tanaka S, Iimuro S, et al.; Japan Diabetes Complications Study Group. Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia 2010;53: 419-428
16. Sone H, Ito H, Saito Y, et al. The long-term effects of self-management education for patients with type 2 diabetes on glycemic control: response to Norris et al. Diabetes Care 2002;25: 2115-2116
17. Kawasaki R, Tanaka S, Tanaka S, et al.; Japan Diabetes Complications Study Group. Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia 2011;54: 2288-2294
18. Makino H, Haneda M, Babazono T, et al.; INNOVATION Study Group. Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes. Diabetes Care 2007; 30: 1577-1578
19. Wilkinson CP, Ferris FL 3rd, Klein RE, et al.; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110: 1677-1682
20. Matsuo S, Imai E, Horio M, et al.; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53: 982-992
21. Murussi M, Gross JL, Silveiro SP. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up. J Diabetes Complications 2006;20: 210-215
22. Kramer CK, Rodrigues TC, Canani LH, Gross JL, Azevedo MJ. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care 2011;34: 1238-1244
23. Kawasaki R, Cheung N, Islam FM, et al.; Multi-Ethnic Study of Atherosclerosis. Is diabetic retinopathy related to subclinical cardiovascular disease? Ophthalmology 2011;118: 860-865
24. Son JW, Jang EH, Kim MK, et al. Diabetic retinopathy is associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus. Diabetes Res Clin Pract 2011;91: 253-259
25. Trevisan R, Vedovato M, Mazzon C, et al. Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline of kidney function in type 2 diabetic patients. Diabetes Care 2002;25: 2026-2031
26. Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis 1998;31: 947-953
27. Chen YH, Chen HS, Tarng DC. More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients. Diabetes Care 2012;35: 803-808
28. Tong PC, Kong AP, So WY, et al. Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus. Diabet Med 2007;24: 741-746
29. Schwartz MM, Lewis EJ, Leonard-Martin T, Lewis JB, Batlle D, Grp CS; The Collaborative Study Group. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. Nephrol Dial Transplant 1998;13: 2547-2552
30. Suzuki Y, Ueno M, Hayashi H, et al. Morphologic study of the kidney in Japanese non-insulin-dependent patients. J Diabet Complications 1991;5: 79-81
31. Fioretto P, Mauer M, Brocco E, et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996;39: 1569-1576
32. Klein R, Knudtson MD, Klein BE, et al. The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes. Diabetologia 2010;53: 1638-1646
33. Nguyen TT, Wong TY. Retinal vascular changes and diabetic retinopathy. Curr Diab Rep 2009;9: 277-283
34. Rudberg S, Osterby R. Decreasing glomerular filtration ratedan indicator of more advanced diabetic glomerulopathy in the early course of microalbuminuria in IDDM adolescents? Nephrol Dial Transplant 1997;12: 1149-1154
35. Moriya T, Tanaka K, Hosaka T, Hirasawa Y, Fujita Y. Renal structure as an indicator for development of albuminuria in normo- and microalbuminuric type 2 diabetic patients. Diabetes Res Clin Pract 2008;82: 298-304
36. Araki S, Haneda M, Sugimoto T, et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 2005;54: 2983-2987
37. Haller H, Ito S, Izzo JL Jr, et al.; ROADMAP Trial Investigators. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011;364: 907-917